Varubi

Product manufactured by Tesaro, Inc.

Application Nr Approved Date Route Status External Links
NDA206500 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Varubi ® Is Indicated In Combination With Other Antiemetic Agents In Adults For The Prevention Of Delayed Nausea And Vomiting Associated With Initial And Repeat Courses Of Emetogenic Cancer Chemotherapy, Including, But Not Limited To, Highly Emetogenic Chemotherapy. Varubi Is A Substance P/neurokinin 1 (Nk1) Receptor Antagonist Indicated In Combination With Other Antiemetic Agents In Adults For The Prevention Of Delayed Nausea And Vomiting Associated With Initial And Repeat Courses Of Emetogenic Cancer Chemotherapy, Including, But Not Limited To, Highly Emetogenic Chemotherapy. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Rolapitant Hydrochloride ROLAPITANT HYDROCHLORIDE ZINC84449858

Comments